Agentix Biopharma CEO, Rudy Mazzocchi, Discusses the Company’s Growth Strategy with The Stock Day Podcast

Nov 11, 2020, 02:00 PM
The Stock Day Podcast welcomed Agentix Biopharma (AGTX)(“the Company”), a biotechnology company focused on the development of synthetic agonists, inverse agonists and antagonists which modulate the endocannabinoid system (ECS). CEO of the Company, Rudy Mazzocchi, joined Stock Day host Everett Jolly. 

Read Full Press Release: